patent for semaglutide As the semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic China patent expiry and new

prospects, where regulatory and market expectations are far less forgiving

Still, insurers and many patients remain eager to define an end point for the treatment

For a clinic that ships within 24 hours, the exit door takes a week to walk through

Diabetes Market Insights, Epidemiology, and Market Forecast 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key diabetes companies, including TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, among others

Always label vials with the reconstitution date and discard anything outside the window